Study Confirms That Levitra® On Demand Is Effective In Patients With ED After Nerve-sparing Prostatectomy

A study published in the European Urology journal demonstrated that Levitra® (vardenafil, HCI) is highly efficacious in men with erectile dysfunction (ED) even shortly after radical nerve-sparing prostatectomy. This landmark study conducted by Bayer Schering Pharma was a double-blind, randomized, placebo-controlled multicentre study, the largest of its kind until.

More: continued here

Filed under: Erectile Dysfunction / Premature Ejaculation on July 31st, 2008